{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:40:32Z","timestamp":1792629632431,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001120"],"award-info":[{"award-number":["UL1 TR001120"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002645"],"award-info":[{"award-number":["UL1 TR002645"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR002647"],"award-info":[{"award-number":["TL1 TR002647"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08DK101602"],"award-info":[{"award-number":["K08DK101602"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R24HS022418"],"award-info":[{"award-number":["R24HS022418"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s40264-019-00873-8","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T12:06:58Z","timestamp":1572955618000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)"],"prefix":"10.1007","volume":"43","author":[{"given":"Taylor M.","family":"Patek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-2125","authenticated-orcid":false,"given":"Chengwen","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin E.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-4787","authenticated-orcid":false,"given":"Christopher R.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"issue":"9843","key":"873_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756\u201366.","journal-title":"Lancet."},{"issue":"1","key":"873_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2215\/CJN.02730313","volume":"9","author":"X Zeng","year":"2014","unstructured":"Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9(1):12\u201320.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"873_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411\u201323.","journal-title":"Intensive Care Med."},{"issue":"4","key":"873_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241\u201357.","journal-title":"Nat Rev Nephrol."},{"issue":"9","key":"873_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1164\/rccm.201311-2097OC","volume":"189","author":"A Linder","year":"2014","unstructured":"Linder A, Fjell C, Levin A, Walley KR, Russell JA, Boyd JH. Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med. 2014;189(9):1075\u201381.","journal-title":"Am J Respir Crit Care Med."},{"issue":"6 Suppl","key":"873_CR6","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1097\/CCM.0b013e3181de0c60","volume":"38","author":"ML Bentley","year":"2010","unstructured":"Bentley ML, Corwin HL, Dasta J. Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies. Crit Care Med. 2010;38(6 Suppl):S169\u201374.","journal-title":"Crit Care Med."},{"issue":"12","key":"873_CR7","first-page":"871","volume":"51","author":"H Khalili","year":"2013","unstructured":"Khalili H, Bairami S, Kargar M. Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. Acta Med Iran. 2013;51(12):871\u20138.","journal-title":"Acta Med Iran."},{"issue":"1","key":"873_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/CCM.0000000000002769","volume":"46","author":"MK Luther","year":"2018","unstructured":"Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante KL. Vancomycin plus piperacillin\u2013tazobactam and acute kidney injury in adults: a systematic review and meta-analysis. Crit Care Med. 2018;46(1):12\u201320.","journal-title":"Crit Care Med."},{"issue":"8","key":"873_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/phar.2152","volume":"38","author":"HK Welch","year":"2018","unstructured":"Welch HK, Kellum JA, Kane-Gill SL. Drug-associated acute kidney injury identified in the United States Food and Drug Administration Adverse Event Reporting System database. Pharmacotherapy. 2018;38(8):785\u201393.","journal-title":"Pharmacotherapy."},{"issue":"4 Suppl","key":"873_CR10","doi-asserted-by":"publisher","first-page":"N75","DOI":"10.1097\/00003246-200104001-00004","volume":"29","author":"GW Waterer","year":"2001","unstructured":"Waterer GW, Wunderink RG. Increasing threat of Gram-negative bacteria. Crit Care Med. 2001;29(4 Suppl):N75\u201381.","journal-title":"Crit Care Med."},{"issue":"1","key":"873_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/ajhp\/62.1.39","volume":"62","author":"D Berlana","year":"2005","unstructured":"Berlana D, Llop JM, Fort E, Badia MB, Jodar R. Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health Syst Pharm. 2005;62(1):39\u201347.","journal-title":"Am J Health Syst Pharm."},{"issue":"6","key":"873_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","volume":"22","author":"RL Nation","year":"2009","unstructured":"Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis. 2009;22(6):535\u201343.","journal-title":"Curr Opin Infect Dis."},{"key":"873_CR13","unstructured":"Food and Drug Administration. FDA Adverse Event Reporting System (FAERS). \nhttps:\/\/www.fda.gov\/drugs\/surveillance\/fda-adverse-event-reporting-system-faers\n\n. Accessed 26 May 2019."},{"key":"873_CR14","unstructured":"Food and Drug Administration. Drugs@FDA: FDA Approved Drug Products. \nhttps:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm\n\n. Accessed 26 May 2019."},{"key":"873_CR15","first-page":"1","volume":"13","author":"KE Evoy","year":"2019","unstructured":"Evoy KE, Teng C, Encarnacion VG, Frescas B, Hakim J, Saklad S, et al. Comparison of quetiapine abuse and misuse reports to the FDA Adverse Event Reporting System with other second-generation antipsychotics. Subst Abuse. 2019;13:1\u20138.","journal-title":"Subst Abuse."},{"issue":"5","key":"873_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7150\/ijms.30739","volume":"16","author":"C Teng","year":"2019","unstructured":"Teng C, Reveles KR, Obodozie-Ofoegbu OO, Frei CR. Clostridium difficile infection risk with important antibiotic classes: an analysis of the FDA Adverse Event Reporting System. Int J Med Sci. 2019;16(5):630\u20135.","journal-title":"Int J Med Sci."},{"issue":"7","key":"873_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.7150\/ijms.34141","volume":"16","author":"C Teng","year":"2019","unstructured":"Teng C, Walter EA, Gaspar DK, Obodozie-Ofoegbu OO, Frei CR. Torsades de pointes and QT prolongation associations with antibiotics: a pharmacovigilance study of the FDA Adverse Event Reporting System. Int J Med Sci. 2019;16(7):1018\u201322.","journal-title":"Int J Med Sci."},{"issue":"10","key":"873_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/phar.1832","volume":"36","author":"KW McConeghy","year":"2016","unstructured":"McConeghy KW, Soriano MM, Danziger LH. A quantitative analysis of FDA Adverse Event Reports with oral bisphosphonates and Clostridium difficile. Pharmacotherapy. 2016;36(10):1095\u2013101.","journal-title":"Pharmacotherapy."},{"issue":"6","key":"873_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"873_CR20","unstructured":"MedDRA MSSO. Introductory Guide for Standardised MedDRA Queries (SMQs) Version 21.0. \nhttps:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/smq_intguide_21_0_english.pdf\n\n. Accessed 26 May 2019."},{"issue":"6","key":"873_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","volume":"18","author":"A Bate","year":"2009","unstructured":"Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18(6):427\u201336.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"3","key":"873_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/molecules24030653","volume":"24","author":"Z Gai","year":"2019","unstructured":"Gai Z, Samodelov SL, Kullak-Ublick GA, Visentin M. Molecular mechanisms of colistin-induced nephrotoxicity. Molecules. 2019;24(3):653.","journal-title":"Molecules."},{"issue":"3","key":"873_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/2042018816638223","volume":"7","author":"O Bamgbola","year":"2016","unstructured":"Bamgbola O. Review of vancomycin-induced renal toxicity: an update. Ther Adv Endocrinol Metab. 2016;7(3):136\u201347.","journal-title":"Ther Adv Endocrinol Metab."},{"issue":"5","key":"873_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother. 1999;43(5):1003\u201312.","journal-title":"Antimicrob Agents Chemother."},{"issue":"11","key":"873_CR25","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2169\/internalmedicine.55.6084","volume":"55","author":"H Wan","year":"2016","unstructured":"Wan H, Hu Z, Wang J, Zhang S, Yang X, Peng T. Clindamycin-induced kidney diseases: a retrospective analysis of 50 patients. Intern Med. 2016;55(11):1433\u20137.","journal-title":"Intern Med."},{"key":"873_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.12659\/AJCR.913779","volume":"20","author":"P Subedi","year":"2019","unstructured":"Subedi P, Chowdhury A, Tanovic K, Dumic I. Clindamycin: an unusual cause of acute kidney injury. Am J Case Rep. 2019;20:248\u201351.","journal-title":"Am J Case Rep."},{"issue":"10","key":"873_CR27","doi-asserted-by":"publisher","first-page":"E475","DOI":"10.1503\/cmaj.121730","volume":"185","author":"ST Bird","year":"2013","unstructured":"Bird ST, Etminan M, Brophy JM, Hartzema AG, Delaney JA. Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ. 2013;185(10):E475\u201382.","journal-title":"CMAJ."},{"issue":"1","key":"873_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12882-019-1399-6","volume":"20","author":"K Luo","year":"2019","unstructured":"Luo K, Lim SW, Jin J, Jin L, Gil HW, Im DS, et al. Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties. BMC Nephrol. 2019;20(1):221.","journal-title":"BMC Nephrol."}],"updated-by":[{"DOI":"10.1007\/s40264-020-00971-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000}}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-019-00873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-019-00873-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-019-00873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T23:24:12Z","timestamp":1602890652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-019-00873-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["873"],"URL":"https:\/\/doi.org\/10.1007\/s40264-019-00873-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40264-020-00971-y","asserted-by":"object"}]},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"assertion":[{"value":"18 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of the article, the second sentence in the figure\ufffd\ufffd2 caption should read as below:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was sought for this research study. Dr. Frei was supported, in part, by a National Institutes of Health Clinical and Translational Science Award (National Center for Advancing Translational Sciences, UL1 TR001120, UL1 TR002645, and TL1 TR002647) while the study was being conducted. Dr. Alvarez received support from the National Institutes of Health (K08DK101602) and Agency for Healthcare Research and Quality (R24HS022418). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Taylor M. Patek, Chengwen Teng, Kaitlin E. Kennedy, Carlos A. Alvarez, and Christopher R. Frei have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing Statement"}}]}}